Evidence map›Paper›PMID 31523485›Full record

ArticleAmerican journal of stem cells2019

Xeno-free trans-differentiation of adipose tissue-derived mesenchymal stem cells into glial and neuronal cells.

Aya Elgamal, Asmaa Althani A, Ahmed Abd-Elmaksoud, Mohammed Kassab, Amany Farag, Samah Lashen, Mahmoud M Gabr, Mahmoud M Zakaria, Mohga M Alissawi, Hossam El-Din Ali Ismail and 4 more

Open access · greenAbstract read
In one paragraph

Article in American journal of stem cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Aya ElgamalDepartment of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University Mansoura, Egypt.
Asmaa Althani ABiomedical Research Center, Qatar University Doha 2713, Qatar.
Ahmed Abd-ElmaksoudDepartment of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University Mansoura, Egypt.
Mohammed KassabDepartment of Cytology and Histology, Faculty of Veterinary Medicine, Kafr ElShiekh University Karf ElShiek, Egypt.
Amany FaragDepartment of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University Mansoura, Egypt.
Samah LashenDepartment of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University Mansoura, Egypt.
Mahmoud M GabrUrology and Nephrology Center, Mansoura University Egypt.
Mahmoud M ZakariaUrology and Nephrology Center, Mansoura University Egypt.
Mohga M AlissawiUrology and Nephrology Center, Mansoura University Egypt.
Hossam El-Din Ali IsmailDepartment of Plastic Surgery, Mansoura University Mansoura, Egypt.
Ahmed Abd El GalilDepartment of Plastic Surgery, Mansoura University Mansoura, Egypt.
Thomas CaceciBiomedical Science Education, Virginia Tech Carilion School of Medicine Roanoke, Virginia.
Carlo Cenciarelli CDepartment of Biomedical Sciences, Institute of Translational Pharmacology-CNR Rome, Italy.
Hany E MareiDepartment of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University Mansoura, Egypt.
Mansoura University · EGQatar University · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are undifferentiated cells that have the ability of self-renewal and trans-differentiation into other cell types. They hold out hope for finding a cure for many diseases. Nevertheless, there are still some obstacles that limit their clinical transplantation. One of these obstacles are the xenogeneic substances added in either proliferation or differentiation media with subsequent immunogenic and infectious transmission problems. In this study, we aimed to replace fetal bovine serum (FBS), the main nutrient source for MSC proliferation with xeno-free blood derivatives. We tested the effect of human activated pure platelet-rich plasma (P-PRP) and advanced platelet-rich fibrin (A-PRF) on the proliferation of human adipose derived-MSCs (AD-MSCs) at different concentrations. For the induction of MSC neural differentiation, we used human cerebrospinal fluid (CSF) at different concentrations in combination with P-PRP to effect xeno-free/species-specific neuronal/glial differentiation and we found that media with 10% CSF and 10% PRP promoted glial differentiation, while media with only 10% PRP induced a neuron-like phenotype.

Indexed as

AD-MSCsA-PRFCSFneural differentiationP-PRP

Identifiers

PMID31523485
PMCPMC6737383
OpenAlexW2979990236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.